EFFECT OF SURGICAL STIMULATION OF OVULATION BY FERTILOSCOPIC OVARIAL DRILLING TO HORMONAL STATUS OF PATIENTS WITH CLOMIPHENE-RESISTANT POLYCYSTIC OVARIAN SYNDROME AND OBESITY

Authors

  • V. V. Chaika P. L. Shupyk National Medical Academy of Postgraduate Education, Kyiv.

DOI:

https://doi.org/10.11603/24116-4944.2020.2.11860

Keywords:

polycystic ovary syndrome, obesity, infertility, clomiphene resistance, surgical stimulation of ovulation, fertiloscopic ovarian drilling, gonadotropins, sex steroids, anti-Müllerian hormone

Abstract

The aim of the study – to learn the influence of surgical stimulation of ovulation by fertiloscopic ovarian drilling on the hormonal status of patients with clomiphene-resistant PCOS and obesity.

Materials and Methods. 61 women of reproductive age were under observation. The main group included 31 women with clomiphene-resistant PCOS and body mass index > 30 kg/m2, who underwent surgical stimulation of ovulation using transvaginal hydrolaparoscopy in the Kyiv City Center for Reproductive and Perinatal Medicine for the period from 2017–2019. The control group included 30 conditionally somatically and gynecologically healthy women. The patients underwent a comprehensive examination. The concentration of gonadotropins, sex steroids and anti-Müllerian hormone in the serum of peripheral blood was investigated by the immunochemical method on days 2–3 of the menstrual cycle before the operation, 1, 3 and 6 months after the operation.

Results and Discussion. After surgical stimulation, there was an improvement in the hormonal profile of the peripheral blood serum with a decrease in luteinizing hormone, sex steroids, and an increase in follicle-stimulating hormone, but after 3 months there was a tendency towards a gradual return of the content of gonadotropins and sex steroids to the initial preoperative level 6 months after surgical stimulation of ovulation, the most stable decrease in comparison with the control values ​​of the concentration of anti-Müllerian hormone in blood serum by 1.24 times (p <0.01), free testosterone – by 1.61 (p <0.01) and dehydroepiandrosterone – 1.69 times (p <0.01). An improvement in the hormonal status immediately after surgical stimulation of ovulation led to the onset of pregnancy in the operated patients within 3 months in 26.81 % of cases, within 6 months – in 35.48 %.

Conclusion. The data obtained indicate that the first 6 months after surgical stimulation of ovulation are the most promising for planning and the onset of pregnancy in clomiphene-resistant patients with PCOS and obesity.

Author Biography

V. V. Chaika, P. L. Shupyk National Medical Academy of Postgraduate Education, Kyiv.

postgraduate student of the Department of Obstetrics, Gynecology and Reproductology, P. L. Shupyk National Medical Academy of Postgraduate Education, Kyiv

References

Popov, A.A., Manannikova, T.N., Loginova, E.A., Slobodyanyuk, B.A., Fedorov, A.A., Lysenko, S.N., ..., & Tyurina S.S. (2015). Laparoskopicheskaya gisterektomiya u bolnykh ozhireniyem [Laparoscopic hysterectomy in obese patients]. Rosiyskiy meditsinskiy zhurnal. Mat i Ditya – Russ. Med. J. Mother and Child, 1, 49 [in Russian].

Urbanovich, A.M. (2018). Syndrom polikistoznykh yaiechnykiv u shchodennii praktytsi [Polycystic ovary syndrome in daily practice]. Mizhnar. Endokrynol. Zhurn. – Int. J. Endocrinol., 14 (1), 40-45. DOI:10.22141/2224-0721.14.1.2018.127090 [in Ukrainian].

Yusubova, V.R. (2017). Laparoskopycheskiy drilling yaichnikov: «za» i «protyv» [Laparoscopic ovarian drilling: “for” and “against”]. Arkhiv akusherstva i ginekologii im. V. F. Snegereva – Arch. Obstet. Gynecol. By V.F. Snegerev, 4 (2), 68-72 [in Russian].

Gilbert, E.W., Tay, C.T., Hiam, D.S., Teede, H.J., & Moran, L.J. (2018). Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews. Clin. Endocrinol. (Oxf)., 89 (6), 683-699. DOI:10.1111/cen.13828.

Kazemi, M., Pierson, R.A., Lujan, M.E., Chilibeck, P.D., McBreairty, L.E., Gordon, J.J., ..., & Chizen, D.R. (2019). Comprehensive evaluation of type 2 diabetes and cardiovascular disease risk profiles in reproductive-age women with polycystic ovary syndrome: a large canadian cohort. J. Obstet. Gynaecol. Can., 41 (10), 1453-1460. DOI:10.1016/j.jogc.2018.11.026.

Aversa, A., La Vignera, S., Rago, R., Gambineri, A., Nappi, R.E., Calogero, A.E., & Ferlin, A. (2020). Fundamental concepts and novel aspects of polycystic ovarian syndrome: expert consensus resolutions. Front. Endocrinol. (Lausanne), 11, 516. DOI:10.3389/fendo.2020.00516.

Glueck, C.J., & Goldenberg, N. (2019). Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism, 92, 108-120. DOI:10.1016/j.metabol.2018.11.002.

Han, Y., Li, Y., & He, B. (2019). GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis. Reprod. Biomed. Online, 39 (2), 332-342. DOI:10.1016/j.rbmo.2019.04.017.

Giampaolino, P., Morra, I., De Rosa, N., Cagnacci, A., Pellicano, M., Di Carlo, C., Nappi, C., & Bifulco, G. (2017). Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: A case-control study. Gynecol. Endocrinol., 33 (9), 690-693. DOI:10.1080/09513590.2017.1310837.

Idicula-Thomas, S., Gawde, U., Bhaye, S., Pokar, K., & Bader, G.D. (2020). Meta-analysis of gene expression profiles of lean and obese PCOS to identify differentially regulated pathways and risk of comorbidities. Comput. Struct. Biotechnol. J., 18, 1735-1745. DOI:10.1016/j.csbj.2020.06.023.

Mitra, S., Nayak, P.K., & Agrawai, S. (2015). Laparoscopic ovarian drilling: an alternative but not the ultimate in the management of polycystic ovary syndrome. J. Nat. Sci. Bio. Med., 6 (1), 40-48. DOI:10.4103/0976-9668.149046.

Seow, K.M., Chang, Y.W., Chen, K.H., Juan, C.-C., Huang, C.-Y., Lin, L.-T., …, & Wang, P.-H. (2020). Molecular mechanisms of laparoscopic ovarian drilling and its therapeutic effects in polycystic ovary syndrome. Int. J. Mol. Sci., 21 (21), 8147. DOI:10.3390/ijms21218147.

Pouly, J.L., Krief, M., Rabischong, B., Brugnon, F., Gremeau, A.S., Dejou, L., ..., & Folini, X. (2013). Ovarian drilling by fertiloscopy: feasibility, results and predictive values. Gynecol. Obstet. Fertil., 41 (4), 235-241. DOI:10.1016/j.gyobfe.2013.02.010.

Fernandez, H., Morin-Surruca, M., Torre, A., Faivre, E., Deffieux, X., & Gervaise, A. (2011). Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive review. Reprod. Biomed. Online., 22 (6), 556-568. DOI: 10.1016/j.rbmo.2011.03.013.

Lebbi, I., Temime, R.B., Fadhlaoui, A., & Feki, A. (2015). Ovarian drilling in PCOS: Is it really useful? Front. Surg., 2, 30. DOI: https://doi.org/10.3389/fsurg.2015.00030.

Pfieffer, M.L. (2019). Polycystic ovary syndrome: An update. Nursing, 49 (8), 34-40. DOI:10.1097/01.NURSE.0000569748.65796.d1.

Wang, F.F., Wu, Y., Zhu, Y.H., Ding, T., Batterham, R.L., Qu, F., & Hardiman, P.J. (2018). Pharmacologic therapy to induce weight loss in women who have obesity/overweight with polycystic ovary syndrome: a systematic review and network meta-analysis. Obes. Rev., 19 (10), 1424-1445. DOI:10.1111/obr.12720.

Zeng, X., Xie, Y.J., Liu, Y.T., Long, S.L., & Mo, Z.C. (2020). Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin. Chim. Acta., 502, 214-221. DOI:10.1016/j.cca.2019.11.003.

McBreairty, L.E., Chilibeck, P.D., Gordon, J.J., Chizen, D.R., & Zello, G.A. (2019). Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study. BMC. Endocr. Disord., 19 (1), 70. DOI:10.1186/s12902-019-0381-4.

Yildiz, B.O., Bozdag, G., Yapici, Z., Esinler, I., & Yarali, H. (2012). Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod., 27 (10), 3067-3073. DOI:10.1093/humrep/des232.

Franz, M., Ott, J., Watrelot, A., Küssel, L., & Husslein, H. (2015). Prospective evaluation of the learning curve of fertiloscopy with and without ovarian drilling. Reprod. Biomed. Online, 30 (4), 408-414. DOI:10.1016/j.rbmo.2014.12.015.

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod., 19 (1), 41-47. DOI:10.1093/humrep/deh098.

Sanchez-Garrido, M.A., & Tena-Sempere, M. (2020). Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol. Metab., 35, 100937. DOI:10.1016/j.molmet.2020.01.001.

Ding, T., Hardiman, P.J., Petersen, I., Wang, F.F., Qu, F., & Baio, G. (2017). The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget, 8 (56), 96351-96358. DOI:10.18632/oncotarget.19180.

Gordts, S., Campo, R., Rombauts, L., & Brosens, I. (1998). Transvaginal hydrolaparoscopy as an outpatient procedure for infertility investigation. Hum. Reprod., 13 (1), 99-103. DOI:10.1093/humrep/13.1.99.

Melo, A.S., Ferriani, R.A., & Navarro, P.A. (2015). Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics (Sao Paulo, Brazil), 70 (11), 765-769. DOI:10.6061/clinics/2015(11)09.

Watrelot, A., Dreyfus, J.M., & Andine, J.P. (1999). Evaluation of the performance of fertiloscopy in 160 consecutive infertile patients with no obvious pathology. Hum. Reprod., 14 (3), 707-711. DOI:10.1093/humrep/14.3.707.

Published

2021-03-04

How to Cite

Chaika, V. V. (2021). EFFECT OF SURGICAL STIMULATION OF OVULATION BY FERTILOSCOPIC OVARIAL DRILLING TO HORMONAL STATUS OF PATIENTS WITH CLOMIPHENE-RESISTANT POLYCYSTIC OVARIAN SYNDROME AND OBESITY. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 179–184. https://doi.org/10.11603/24116-4944.2020.2.11860

Issue

Section

OBSTETRICS AND GYNECOLOGY